BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 24829351)

  • 1. Faster replication and higher expression levels of viral glycoproteins give the vesicular stomatitis virus/measles virus hybrid VSV-FH a growth advantage over measles virus.
    Ayala-Breton C; Russell LO; Russell SJ; Peng KW
    J Virol; 2014 Aug; 88(15):8332-9. PubMed ID: 24829351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
    Ayala-Breton C; Barber GN; Russell SJ; Peng KW
    Hum Gene Ther; 2012 May; 23(5):484-91. PubMed ID: 22171635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor (CD46)- and replication-mediated interleukin-6 induction by measles virus in human astrocytoma cells.
    Ghali M; Schneider-Schaulies J
    J Neurovirol; 1998 Oct; 4(5):521-30. PubMed ID: 9839649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.
    Tatsuo H; Okuma K; Tanaka K; Ono N; Minagawa H; Takade A; Matsuura Y; Yanagi Y
    J Virol; 2000 May; 74(9):4139-45. PubMed ID: 10756026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of receptor (CD46, CD150) usage by measles virus.
    Erlenhöfer C; Duprex WP; Rima BK; Ter Meulen V; Schneider-Schaulies J
    J Gen Virol; 2002 Jun; 83(Pt 6):1431-1436. PubMed ID: 12029158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of nectin4 binding compromises CD46 usage by a hybrid vesicular stomatitis virus/measles virus.
    Liu YP; Russell SP; Ayala-Breton C; Russell SJ; Peng KW
    J Virol; 2014 Feb; 88(4):2195-204. PubMed ID: 24335299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and structural interactions between measles virus hemagglutinin and CD46.
    Nussbaum O; Broder CC; Moss B; Stern LB; Rozenblatt S; Berger EA
    J Virol; 1995 Jun; 69(6):3341-9. PubMed ID: 7745681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer.
    Liu YP; Steele MB; Suksanpaisan L; Federspiel MJ; Russell SJ; Peng KW; Bakkum-Gamez JN
    Gynecol Oncol; 2014 Jan; 132(1):194-202. PubMed ID: 24246772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles virus glycoprotein complex assembly, receptor attachment, and cell entry.
    Navaratnarajah CK; Leonard VH; Cattaneo R
    Curr Top Microbiol Immunol; 2009; 329():59-76. PubMed ID: 19198562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus.
    Manchester M; Liszewski MK; Atkinson JP; Oldstone MB
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2161-5. PubMed ID: 8134365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant measles viruses efficiently entering cells through targeted receptors.
    Schneider U; Bullough F; Vongpunsawad S; Russell SJ; Cattaneo R
    J Virol; 2000 Nov; 74(21):9928-36. PubMed ID: 11024120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium.
    Seya T; Kurita M; Iwata K; Yanagi Y; Tanaka K; Shida K; Hatanaka M; Matsumoto M; Jun S; Hirano A; Ueda S; Nagasawa S
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):135-44. PubMed ID: 9078253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A wild-type Japanese measles virus strain inducing predominant early down-regulation of CD46.
    Sakata H; Kurita M; Murakami Y; Nagasawa S; Watanabe M; Ueda S; Matsumoto M; Sato T; Kobune F; Seya T
    Biol Pharm Bull; 1998 Nov; 21(11):1121-7. PubMed ID: 9853398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor use by vesicular stomatitis virus pseudotypes with glycoproteins of defective variants of measles virus isolated from brains of patients with subacute sclerosing panencephalitis.
    Shingai M; Ayata M; Ishida H; Matsunaga I; Katayama Y; Seya T; Tatsuo H; Yanagi Y; Ogura H
    J Gen Virol; 2003 Aug; 84(Pt 8):2133-2143. PubMed ID: 12867645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus.
    Anderson BD; Nakamura T; Russell SJ; Peng KW
    Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.
    Hashimoto K; Ono N; Tatsuo H; Minagawa H; Takeda M; Takeuchi K; Yanagi Y
    J Virol; 2002 Jul; 76(13):6743-9. PubMed ID: 12050387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human receptor for measles virus (CD46) enhances nitric oxide production and restricts virus replication in mouse macrophages by modulating production of alpha/beta interferon.
    Katayama Y; Hirano A; Wong TC
    J Virol; 2000 Feb; 74(3):1252-7. PubMed ID: 10627535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles fusion machinery is dysregulated in neuropathogenic variants.
    Jurgens EM; Mathieu C; Palermo LM; Hardie D; Horvat B; Moscona A; Porotto M
    mBio; 2015 Feb; 6(1):. PubMed ID: 25670774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers.
    Nagalo BM; Breton CA; Zhou Y; Arora M; Bogenberger JM; Barro O; Steele MB; Jenks NJ; Baker AT; Duda DG; Roberts LR; Russell SJ; Peng KW; Borad MJ
    Mol Ther Oncolytics; 2020 Sep; 18():546-555. PubMed ID: 32839735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficiency of measles virus entry and dissemination through different receptors.
    Schneider U; von Messling V; Devaux P; Cattaneo R
    J Virol; 2002 Aug; 76(15):7460-7. PubMed ID: 12097558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.